Over 12,340 lawsuits have been filed against Sanofi-Aventis with regard to allegations about complications stemming from the defendants’ chemotherapy drug, Taxotere. The plaintiffs claim that the defendants failed to provide adequate warnings to doctors and patients about the risk of permanent hair loss from this... Read More

Five bellwether trials have been scheduled for plaintiffs who filed federal lawsuits against Sanofi-Aventis regarding the alleged complications of the defendants’ drug, Taxotere. The U.S. District Judge presiding over the Taxotere lawsuits has scheduled the group of trials to begin in May 2019. Bellwether trials... Read More

On March 9, four representative cases were chosen as the first to be tried in a series of bellwether trials regarding Sanofi-Aventis’s Taxotere (docetaxel). The drug manufacturer currently faces over 5,600 product liability cases alleging that the drug, prescribed for treatment of breast cancer, causes... Read More

Pursuant to an October 10 transfer order filed by the United States Judicial Panel on Multidistrict Litigation, cases involving claims against the maker of breast cancer drug Taxotere have been consolidated under the supervision of U.S. District Judge Lance Africk in the Eastern District of... Read More

A Minnesota woman alleges she suffered permanent hair loss after taking the chemotherapy drug Taxotere to treat her breast cancer. The plaintiff also concludes in her complaint that the manufacturers of the drug failed to warn of this side effect and falsely touted their drug... Read More

A Louisiana woman filed suit on June 17,  alleging that her use of breast cancer drug Taxotere (docetaxel) resulted in permanent alopecia, or a total failure of her hair to regrow following treatment with the medication. According to the complaint, drug maker Sanofi-Aventis failed in... Read More

A Texas woman has filed a lawsuit against the manufacturer of the drug Taxotere, alleging the chemotherapy drug left her with permanent baldness. The lawsuit is just one of a growing number of claims filed by women who argue that the manufacturer of the drug failed to... Read More

Temporary hair loss has come to be expected of chemotherapy. In fact, along with nausea, hair loss is arguably among the most well-known side effects of anti-cancer drugs. Cancer patients tolerate this troublesome side effect because of the hope that the drug will save their... Read More